Trials Sponsors Conditions Drugs Pricing

Conditions

Acute Kidney Injury

Keywords

Glomerular Filtration Rate

Outcome Measures

Primary Outcomes (1)

Mean Background Fluorescence
Two separate Brilliance device sensors will be attached via standard adhesive pads to the left and right pectoralis major on each participant. Fluorescence measurements will be collected directly by the MediBeacon Transdermal GFR Measurement System Brilliance device, and will be continuously collected throughout the 48 hour study.
From the time of sensor placement to 48 hours after placement

Study Arms (1)

Participants with Brilliance sensor placement

EXPERIMENTAL

Brilliance device sensors placed on the left and right pectoralis major, remaining for 48 hours

Device: Brilliance device sensor

Interventions

Brilliance device sensorDevice

Two separate sensors will be attached via standard, single-use adhesive pads to the left and right pectoralis major on each participant.

Participants with Brilliance sensor placement

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 99 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Healthy male and female adults age 18 and older
age cohorts to be recruited: 18 - 50 years of age and 51+ years or older

Sponsors & Collaborators

MediBeacon
Industrylead

Study Sites (1)

St. Louis Clinical Trials

St Louis, Missouri, 63141, United States

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

Richard B Dorshow, PhD
MediBeacon
STUDY DIRECTOR

Enrollment

12 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: DEVICE FEASIBILITY
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

January 17, 2019

First Posted

January 22, 2019

Study Start

September 16, 2019

Actual (reported)

Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Participants with Brilliance sensor placement

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Participants with Brilliance sensor placement

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations